Global Peptide API Market Opportunities, Growth and Forecast Report 2025

Posted by rekha on August 29th, 2019

Precision Business Insights (PBI) in its report titled “Global Peptide API Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global peptide API market was valued at US$ XX Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the scientific advancements and rising number of pharmaceutical and biopharmaceutical companies across the globe are expected to propel the growth of the market. Additionally, launch of novel technologies and strategic collaborations between the market players are expected to enhance the sales of the peptide API market. However manufacturing peptide API is a complex process that involves sophisticated technology and expert oversight are expected to hamper the growth of the market

 Global peptide API market segmented on the basis of category, therapeutic area, end user, and region

 For request sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=30823

 Cancer Area Dominates the Global Peptide API Market

 Based on therapeutic area, global peptide API market segmented into Cancer, Cardiovascular, Respiratory, Nervous Systems, Gastrointestinal, Others.Among them cancer area dominated the global peptide API market in 2018 and estimated to dominate over the forecast period owing to increase in prevalence of various types of cancers. According to World Health Organization 2018, approximately 9.6 Mn deaths occurred due to cancer around the globe, and the use of conventional drugs cannot cure the disease, innovation of newer protein and peptide drugs by the companies, rise in awareness about the peptide API among the people, and patent filings by the market players are surge the market over the forecast years. However, a slow growth rate observed for the chromatography due to the presence of less number of products and not showing much interest on these products.

North America Leads the Global Peptide API Market

 PBI’s global peptide API market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to increasing number of research activities and advancements in technologies and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Moreover, increasing prevalence of chronic diseases such as cancer, cardiovascular and autoimmune diseases and rising focus on development of new products and drugs are expected to drive the growth of the market. Europe and Asia Pacific region are expected to grow at a significant growth rate over the forecast years.

 

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

 Global peptide API market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

Key player’s profiles in the report are

  • CordenPharma
  • Hemmo Pharmaceuticals Pvt Ltd.
  • Auspep (Australia)
  • BACHEM
  • BAM Biotech Company
  • CS Bio (California)
  • Almac Group
  • Tapi Teva
  • Novetide
  • Lyotex Sciences
  • Aspen Oss
  • Peptide Institute Inc.

Detailed Segmentation

 

By Category

o     Biologically Active Peptides

o     Enzyme Inhibitors

o     Polypeptides

o     Oligopeptides

o     Others

By Therapeutic Area 

o     Cancer

o     Cardiovascular

o     Respiratory

o     Nervous Systems

o     Gastrointestinal

o     Others

By End User 

o     Biopharmaceutical Companies

o     Pharmaceutical Companies

o     Research Institutes & Universities

o     Others

Geography

o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-peptide-api-market/

Like it? Share it!


rekha

About the Author

rekha
Joined: July 26th, 2019
Articles Posted: 219

More by this author